Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer |
Lee, Hyebin
(Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Hee Chul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park, Won (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Choi, Doo Ho (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Young-Il (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park, Young Suk (Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park, Joon Oh (Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Chun, Ho-Kyung (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Woo-Yong (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Hee Cheol (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) Yun, Seong Hyeon (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) Cho, Yong Beom (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park, Yoon Ah (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982;69:613-6. DOI ScienceOn |
2 | Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82. |
3 | Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46. DOI ScienceOn |
4 | Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefi t in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701. DOI ScienceOn |
5 | Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers:impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87. DOI ScienceOn |
6 | Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995; 13:2077-83. DOI |
7 | Tanvetyanon T, Choudhury AM. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma. Cancer 2006;106:1554-9. DOI ScienceOn |
8 | Pradier O, Lederer K, Hille A, et al. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin Oncol 2005;131:261-9. DOI ScienceOn |
9 | MacRae R, Shyr Y, Johnson D, Choy H. Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is signifi cant. Radiother Oncol 2002;64:37-40. DOI ScienceOn |
10 | Neuhof D, Neumayer F, Einbeck W, et al. Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer. Acta Oncol 2005;44:168-73. DOI ScienceOn |
11 | Zenda S, Hironaka S, Boku N, et al. Impact of hemoglobin level on survival in defi nitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. Dis Esophagus 2008;21:195-200. DOI ScienceOn |
12 | Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006;107:1747-50. DOI ScienceOn |
13 | Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic signifi cance and treatment. Oncology 2002;63 Suppl 2:11-8. DOI |
14 | Box B, Lindsey I, Wheeler JM, et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum 2005;48:1153-60. DOI ScienceOn |
15 | Berardi R, Braconi C, Mantello G, et al. Anemia may infl uence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer. Ann Oncol 2006;17:1661-4. DOI ScienceOn |
16 | Rades D, Kuhn H, Schultze J, et al. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Int J Radiat Oncol Biol Phys 2008;70:1087-93. DOI ScienceOn |
17 | Lee SD, Park JW, Park KS, et al. Infl uence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2009;24:1451-8. DOI ScienceOn |
18 | Park HC, Janjan NA, Mendoza TR, et al. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2009;75:775-81. DOI ScienceOn |
19 | Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B; Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer pati ents receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-74. DOI |
20 | Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34:4-12. |
21 | Cella D, Bron D. The effect of Epoetin alfa on quality of life in anemic cancer patients. Cancer Pract 1999;7:177-82. DOI |
22 | Rizzo JD, Brouwers M, Hurley P, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010;28:4996-5010. DOI ScienceOn |
23 | Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-60. DOI ScienceOn |
24 | Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer. J Clin Oncol 2009;27:5751-6. DOI ScienceOn |